LYR-220, Lyra Therapeutics’ second product candidate, is in Phase 2 development for chronic rhinosinusitis (CRS) patients who have undergone a prior sinus surgery but continue to have …

We recently announced the start of our Phase 2 BEACON clinical trial of LYR-220 for use in CRS patients who still struggle with the condition despite having had sinus surgery. LYR-220 is a …

2022年9月13日 · LYR-220 is an investigational product candidate that utilizes Lyra's proprietary XTreo™ platform to enable six months of local, intra-nasal, anti-inflammatory therapy from a …

Any person who has participated in any therapy conducted under the supervision of a licensee, registrant, or certificate holder, including group therapy sessions, shall not disclose any …

2023年9月12日 · LYR-220, Lyra’s second product candidate, is a long-acting anti-inflammatory therapy in development for CRS patients with and without polyps who have recurrent …

LYR-220 is an investigational product candidate that utilizes Lyra's proprietary XTreo platform to enable six months of local, intra-nasal, anti-inflammatory therapy from a single treatment for …

2024年9月27日 · Lyra Therapeutics is developing therapies for CRS, a highly prevalent inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and …

CRS 【Common Reporting Standard】即“共同申报准则”或“统一报告标准”，是经济合作与发展组织「OECD」在 2014 年提出的，旨在通过加强全球税收合作，提高 税收透明度 ，打击利用 …

2024年8月9日 · crs，即冷轧钢，是一种在室温下在再结晶温度以下通过进一步轧制将钢板减薄至特定厚度的金属材料。 相较于热轧钢板，冷轧钢板具有更精确的厚度控制，表面光滑，外观 …

Rugged Ringo CRS-150 and CRS-220, 2 dBi gain Our Ringo is a single half-wave, end-fed antenna with a matching section featuring a ring inductor. With a frequency range of 150-174 …